José Marco‐Contelles

12.0k total citations · 2 hit papers
323 papers, 9.8k citations indexed

About

José Marco‐Contelles is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, José Marco‐Contelles has authored 323 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 225 papers in Organic Chemistry, 131 papers in Pharmacology and 84 papers in Molecular Biology. Recurrent topics in José Marco‐Contelles's work include Cholinesterase and Neurodegenerative Diseases (117 papers), Computational Drug Discovery Methods (59 papers) and Chemical synthesis and alkaloids (43 papers). José Marco‐Contelles is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (117 papers), Computational Drug Discovery Methods (59 papers) and Chemical synthesis and alkaloids (43 papers). José Marco‐Contelles collaborates with scholars based in Spain, France and Tunisia. José Marco‐Contelles's co-authors include Elena Soriano, Abdelouahid Samadi, Antonio G. Garcı́a, Rafael León, María do Carmo Carreiras, Mourad Chioua, María Jesús Oset‐Gasque, Cristóbal de los Rı́os, Mércedes Villarroya and Alejandro Romero and has published in prestigious journals such as Chemical Reviews, Journal of the American Chemical Society and Chemical Society Reviews.

In The Last Decade

José Marco‐Contelles

312 papers receiving 9.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recent Advances in the Friedländer Reaction

2009 588 citations José Marco‐Contelles, María do Carmo Carreiras et al. profile →
Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer's disease

2011 390 citations José Marco‐Contelles et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
José Marco‐Contelles Spain	51	6.6k	3.7k	2.2k	2.1k	1.2k	323	9.8k
María Laura Bolognesi Italy	50	3.1k 0.5×	4.4k 1.2×	3.1k 1.4×	3.2k 1.5×	2.1k 1.7×	200	9.2k
Angelo Carotti Italy	47	3.3k 0.5×	2.1k 0.6×	2.3k 1.1×	1.6k 0.7×	441 0.4×	196	7.2k
Arnold Brossi United States	42	3.1k 0.5×	2.0k 0.5×	2.1k 0.9×	894 0.4×	636 0.5×	255	6.5k
Vincenza Andrisano Italy	54	3.1k 0.5×	5.9k 1.6×	2.9k 1.3×	4.0k 1.9×	2.4k 2.0×	242	10.1k
Manuela Bartolini Italy	52	2.9k 0.4×	5.6k 1.5×	2.4k 1.1×	3.9k 1.8×	2.2k 1.8×	158	8.2k
Bijo Mathew India	42	1.9k 0.3×	1.9k 0.5×	1.6k 0.7×	961 0.4×	934 0.8×	244	5.8k
Carlo Melchiorre Italy	40	2.1k 0.3×	3.3k 0.9×	2.8k 1.3×	2.1k 1.0×	1.5k 1.2×	178	6.5k
Michela Rosini Italy	36	1.6k 0.2×	3.0k 0.8×	1.6k 0.7×	1.9k 0.9×	1.2k 1.0×	94	4.9k
Marco Catto Italy	38	2.3k 0.3×	2.0k 0.6×	1.2k 0.6×	1.3k 0.6×	492 0.4×	127	4.5k
Mi Hee Lim South Korea	55	1.6k 0.2×	1.8k 0.5×	3.1k 1.4×	1.4k 0.7×	3.9k 3.2×	182	11.2k

Countries citing papers authored by José Marco‐Contelles

Since Specialization

Citations

This map shows the geographic impact of José Marco‐Contelles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José Marco‐Contelles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José Marco‐Contelles more than expected).

Fields of papers citing papers by José Marco‐Contelles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José Marco‐Contelles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José Marco‐Contelles. The network helps show where José Marco‐Contelles may publish in the future.

Co-authorship network of co-authors of José Marco‐Contelles

This figure shows the co-authorship network connecting the top 25 collaborators of José Marco‐Contelles. A scholar is included among the top collaborators of José Marco‐Contelles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José Marco‐Contelles. José Marco‐Contelles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iriepa, Isabel, Marialessandra Contino, Carmen Abate, & José Marco‐Contelles. (2025). Zervimesine, a Small Sigma-2 Receptor Selective Modulator for Alzheimer’s Disease. ACS Medicinal Chemistry Letters. 16(12). 2371–2372.

Marco‐Contelles, José, Isabel Iriepa, María do Carmo Carreiras, et al.. (2025). Multicomponent Synthesis of Multi-Target Quinazolines Modulating Cholinesterase, Oxidative Stress, and Amyloid Aggregation Activities for the Therapy of Alzheimer’s Disease. Molecules. 30(19). 3930–3930.

Entrena, José Manuel, et al.. (2024). The proof of concept of 2-{3-[N-(1-benzylpiperidin-4-yl)propyl]amino}-6-[N-methyl-N-(prop-2-yn-1-yl)amino]-4-phenylpyridine-3,5-dicarbonitrile for the therapy of neuropathic pain. Bioorganic Chemistry. 150. 107537–107537. 2 indexed citations

Marco‐Contelles, José. (2024). α-Phenyl-N-tert-Butylnitrone and Analogous α-Aryl-N-alkylnitrones as Neuroprotective Antioxidant Agents for Stroke. Antioxidants. 13(4). 440–440. 8 indexed citations

Hadjipavlou‐Litina, Dimitra, Iwona E. Głowacka, José Marco‐Contelles, & Dorota G. Piotrowska. (2024). Synthesis and Antioxidant Activity of N-Benzyl-2-[4-(aryl)-1H-1,2,3-triazol-1-yl]ethan-1-imine Oxides. International Journal of Molecular Sciences. 25(11). 5908–5908. 1 indexed citations

Šinko, Goran, Ludovic Jean, Mourad Chioua, et al.. (2024). Cholesterol Oxime Olesoxime Assessed as a Potential Ligand of Human Cholinesterases. Biomolecules. 14(5). 588–588. 1 indexed citations

Herrero-Labrador, Raquel, Daniel González‐Nieto, Mohamed Benchekroun, et al.. (2023). The Proof-of-Concept of MBA121, a Tacrine–Ferulic Acid Hybrid, for Alzheimer’s Disease Therapy. International Journal of Molecular Sciences. 24(15). 12254–12254. 2 indexed citations

Knez, Damijan, Stanislav Gobec, Isabel Iriepa, et al.. (2022). Polyfunctionalized α-Phenyl-tert-butyl(benzyl)nitrones: Multifunctional Antioxidants for Stroke Treatment. Antioxidants. 11(9). 1735–1735. 6 indexed citations

Chrienová, Žofia, Eugenie Nepovimová, Rudolf Andrýs, et al.. (2022). Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 2605–2620. 9 indexed citations

10.

Bernard, Paul J., et al.. (2022). Benzochromenopyrimidines: Synthesis, Antiproliferative Activity against Colorectal Cancer and Physicochemical Properties. Molecules. 27(22). 7878–7878. 4 indexed citations

11.

Aliena‐Valero, Alicia, Germán Torregrosa, Mourad Chioua, et al.. (2022). Preclinical Characterization of Antioxidant Quinolyl Nitrone QN23 as a New Candidate for the Treatment of Ischemic Stroke. Antioxidants. 11(6). 1186–1186. 8 indexed citations

12.

Iriepa, Isabel, et al.. (2022). Synthesis and Antioxidant Properties of HeteroBisNitrones Derived from Benzene Dicarbaldehydes. Antioxidants. 11(8). 1575–1575. 2 indexed citations

13.

Pérez, Marta, et al.. (2021). Efficacy of Acetylcholinesterase Inhibitors on Cognitive Function in Alzheimer’s Disease. Review of Reviews. Biomedicines. 9(11). 1689–1689. 64 indexed citations

14.

Ayuso, María Irene, Rafael Gonzalo‐Gobernado, Mourad Chioua, et al.. (2020). Characterization of a CholesteroNitrone (ISQ-201), a Novel Drug Candidate for the Treatment of Ischemic Stroke. Antioxidants. 9(4). 291–291. 12 indexed citations

15.

Mezeiová, Eva, Jana Janočková, Rudolf Andrýs, et al.. (2020). 2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer’s disease. European Journal of Medicinal Chemistry. 211. 113112–113112. 25 indexed citations

16.

Więckowska, Anna, Adam Bucki, Gniewomir Latacz, et al.. (2020). In Vitro and In Silico ADME-Tox Profiling and Safety Significance of Multifunctional Monoamine Oxidase Inhibitors Targeting Neurodegenerative Diseases. ACS Chemical Neuroscience. 11(22). 3793–3801. 8 indexed citations

17.

Hagenow, Stefanie, et al.. (2018). Novel indanone derivatives as MAO B/H3R dual-targeting ligands for treatment of Parkinson’s disease. European Journal of Medicinal Chemistry. 148. 487–497. 44 indexed citations

18.

Ayuso, María Irene, Mourad Chioua, Rafael Gonzalo‐Gobernado, et al.. (2017). Quinolinyl Nitrone RP19 Induces Neuroprotection after Transient Brain Ischemia. ACS Chemical Neuroscience. 8(10). 2202–2213. 23 indexed citations

19.

Romero, Alejandro, Eva Ramos, María Jesús Oset‐Gasque, et al.. (2016). Melatonin and Nitrones As Potential Therapeutic Agents for Stroke. Frontiers in Aging Neuroscience. 8. 281–281. 10 indexed citations

20.

Chioua, Mourad, Marta Pérez, Óscar M. Bautista‐Aguilera, et al.. (2015). Development of HuperTacrines as Non-Toxic, Cholinesterase Inhibitors for the Potential Treatment of Alzheimer’s Disease. Mini-Reviews in Medicinal Chemistry. 15(8). 648–658. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact